Ensuring Access to COVID-19 Preventive Care Act of 2020
Do you support it?
Want to know if it passes?
We'll email you when HR 6231 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 6231.
You're tracking HR 6231
We'll email you the moment it moves.
HR 6231 — Ensuring Access to COVID-19 Preventive Care Act of 2020
Last action — Referred to the House Committee on Energy and Commerce.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Requires private health insurance plans to cover diagnostic tests for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing. The requirement applies only: (1) to tests designated by the Department of Health and Human Services, and (2) during the public health emergency declared on January 31, 2020.The bill also shortens to 15 business days the time frame under which the Advisory Committee on Immunization Practices must issue a recommendation after a vaccine intended to treat or prevent COVID-19 is licensed by the Food and Drug Administration.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 6231 on the official United States source →Action History
-
Referred to the House Committee on Energy and Commerce.
-
Introduced in House
Sponsors
- Larry Bucshon · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 6231 do?
- Requires private health insurance plans to cover diagnostic tests for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing. The requirement applies only: (1) to tests designated by the Department of Health and Human Services, and (2) during the public health emergency declared on January 31, 2020.The bill also shortens to 15 business days the time frame under which the Advisory Committee on Immunization Practices must issue a recommendation after a vaccine intended to treat or prevent COVID-19 is licensed by the Food and Drug Administration.
- Who sponsors HR 6231?
- HR 6231 is sponsored by Larry Bucshon (R).
- What is the current status of HR 6231?
- This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 6231?
- Track HR 6231 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 6231
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 6231
Last checked for changes about 13 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →